Abstract
The introduction of stage-independent prognostic markers may play a significant role in future selection for adjuvant treatment for early-stage colorectal cancer (CRC). The purpose of this study was to assess the combination of preoperative serum carcinoembryonic antigen (CEA) and plasma tissue inhibitor of metalloproteinases (TIMP)-1 as a prognostic index in patients with primary, curatively resected CRC.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Scandinavian Journal of Gastroenterology |
Vol/bind | 45 |
Udgave nummer | 2 |
Sider (fra-til) | 200-7 |
Antal sider | 8 |
ISSN | 0036-5521 |
DOI | |
Status | Udgivet - 2010 |